EQ-5D-5L and SF-6DV2 utility comparison of blood cancer patients with QLU-C10D utility comparison

Estimation of preference-based health measurements in Brazier, J., Roberts, J., Deverill, M.: SF-36. J. Health Econ. 21(2), 271–292 (2002)

National Health Care and Excellent Research Institute. Guide to technical evaluation methods. https://www.nice.org.uk/process/pmg9/chapter/forreword. Approach on December 13, 2023.

Tordrup, D., Mossman, J., Kanavos, P.: EQ-5D’s reactivity to clinical change: Is the patient experience appropriately represented? int. J. Technol. evaluate. Health care 30(1), 10–19 (2014)

KING, MT, COSTA, DS, Aaronson, NK, etc. Qual. Life res. 25(3), 625–636 (2016)

Cass
PubMed

Aaronson, NK, Ahmedzai, S., Bergman, B., et al. : Research and treatment of cancer QLQ-C30: Quality tools of life for use in international clinical trials of oncology. J. NATL. Cancer inst. 85(5), 365–376 (1993)

Cass
PubMed

PAN, CW, HE, JY, ZHU, YB, Zhao, Ch, Luo, N., WANG, P.: Comparison of EQ-5D-5L and EORTC QLU-C10D Utility in Patients with gastric cancer. EUR. J. Health Econ. 24(6), 885–893 (2023)

Shaw, JW, Bennett, B., Trigg, A., et al. : General and conditions using data from the Nivolumab test-specific preference-based measurement: EQ-5D-3L, EQ-5D-5L, European Organization for Life Quality of Life, Emulsion Ability Measurement 10 European Tissue of Tissue. Value health. 24(11), 1651–1659 (2021)

Bulamu, NB, VissApragada, R., Chen, G. etc, etc. Health Qual. Result 19(1), 233 (2021)

SOARE, IA, LEEUWENKAMP, O., Longworth, L.: ERTC QLQ-C30 to EQ-5D-3L and QLU-C10D utility estimates health-related utility for 177lu-dotate patients in GEP-NET patients. Open pharmacoecon. 5(4), 715–725 (2021)

Bulamu, Nb, Chen, G., Ratcliffe, J. World J. Surg. 43(6), 1554–1562 (2019)

Norman, R., Cronin, P., Viney, R.: EQ-5D-5L Pilot Selection Experiment to explore the preference for health status. Application health economy. Health policy 11(3), 287–298 (2013)

XIE, F., Pullenayegum, E., Gaebel, K., et al. : A time trade-off derivative set of EQ-5D-5L in Canada. Med. care 54(1), 98–105 (2016)

Luo, N., Liu, G., Li, M., Guan, H., Jin, X., rand-hendriksen, k.: EQ-5D-5L value of China. Value health. 20(4), 662–669 (2017)

ANDRADE, LF, LUDWIG, K., GONI, JMR, etc.: French value for EQ-5D-5L. Pharmaceutical 38(4), 413–425 (2020)

German value set of Ludwig, K., Graf von der schulenburg Pharmaceutical 36(6), 663–674 (2018)

Dutch tariffs on the five-step version of M Versteeeg M, M Vermeulen K, MAA EVERS S, De Wit Ga, PreanGer R, A Stolk E. (2016) EQ-5D. Value health. 19 (4): 343-352

Golicki, D., Jakubczyk, M., Graczyk, K., et al. : Poland’s EQ-5D-5L Health State Evaluation: The first EQ-VT-based study of central and Eastern Europe. Pharmaceutical 37(9), 1165–1176 (2019)

RAMOS-GONI, JM, CRAIG, BM, OPPE, M., etc.: Data quality problems are used to estimate the Spanish EQ-5D-5L value using hybrid interval return approach. Value health 21(5), 596–604 (2018)

Devlin, NJ, Shah, Kk, Feng, Y. etc: Health-related quality of life: UK’s EQ-5D-5L value. Health economy. 27(1), 7–22 (2018)

Pickard, AS, Law, EH, Jiang, R. etc, etc. Value health. 22(8), 931–941 (2019)

Mulhern, B., Norman, R., Brazier, J.: SF-6DV2 evaluation in Australia using international protocols. Pharmaceutical 39(10), 1151–1162 (2021)

XIE, S., WU, J., XIE, F.: Censused of China’s SF-6DV2 and EQ-5D-5L. Application health economy. Health policy 20(4), 573–585 (2022)

Mulhern, BJ, Bansback, N., Norman, R., Brazier, J.: SF-6DV2 International Project Group. Use individual selection experiments using the period to evaluate the UK’s SF-6DV2 classification system. Med Care. 58(6), 566–573 (2020)

King, MT, VINEY, R., Simon Pickard, A., et al. : Australian utility weight of EORTC QLU-C10D, a multi-orthodontic utility tool derived from the questionnaire of cancer-specific quality of life. Pharmaceutical 36(2), 225–238 (2018)

MCTAGART-COWAN, H., King, MT, Norman, R., et al. : EORTC QLU-C10D: Canadian evaluation research and algorithms for deriving cancer specific utility from EORTC QLQ-C30. MDM policy practice. 4(1), 2381468319842532 (2019)

Nerich, V., GAMPER, EM, NORMAN, R. etc, etc. Application health economy. Health policy 19(2), 191–202 (2021)

Kemmler, G., Gamper, E., Nerich, V., et al. : The German value set of EORTC QLU-C10D, which is a cancer utility tool based on EORTC QLQ-C30. Qual. Life res. 28(12), 3197–3211 (2019)

Jansen, F., Verdonck-De Leeuw, IM, Gamper, E. : EORTC cancer specific utility tools of the Dutch utility weight: Dutch EORTC QLU-C10D. Qual. Life res. 30(7), 2009–2019 (2021)

GAMPER, EM, King, MT, Norman, R. etc, etc. Qual. Life res. 29(9), 2485–2495 (2020)

Cass
PubMed
PUBMED CENTRAL

FINCH, AP, GAMPER, E., Norman, R., et al. : Estimates the EORTC QLU-C10 value for Spain using individual selection experiments. Pharmaceutical 39(9), 1085–1098 (2021)

Norman, R., Mercius-Bebber, R., Rowen, D., et al. : EORTC QLU-C10D British utility weight. Health economy. 28(12), 1385–1401 (2019)

Revicki, DA, King, MT, Viney, R., et al. : American utility algorithm for EORTC QLU-C10D, a multi-street utility tool based on a lifetime of cancer-specific life. Med. decision. making 41(4), 485–501 (2021)

Carbone, PP, Kaplan, HS, Musshoff, K., Smithers, DW, Tubiana, M.: Hodgkin’s Disease Classification Committee Report. Cancer res. 31(11), 1860–1861 (1971)

Cass
PubMed

Palumbo, A., Avet-Loiseau, H., Oliva, S., et al. : Revision of the International Reserve for Multiple Bone Marries: Report of the International Barbage Group. J. Clin. Oncol. 33(26), 2863–2869 (2015)

Cass
PubMed
PUBMED CENTRAL

Wahl, RL, Jacene, H., Kasamon, Y., Lodge, MA: From Recist to PERCIST: Evolving of PET reaction standards in solid tumors. J nUCL Med 50(SUPPL 1), 122s – 50s (2009)

Cass
PubMed

Ren, L., Ren, Y., yang, y., et al. : Clinical profiles of multiple myeloma patients with extreme survival: Study of the National Medical Center in China. hematology 28(1), 2277503 (2023)

BLAND, JM, Altman, DG: statistical method for assessing the consensus between the two clinical measurement methods. lance 1(8476), 307–310 (1986)

Cass
PubMed

Mukaka, MM: Statistical Corner: A guide for proper use of correlation in medical studies. Malawi Med. J. 24(3), 69–71 (2012)

Cass
PubMed
PUBMED CENTRAL

XIE, S., Li, M., WANG, D., HONG, T., Guo, W., Wu, J. Health Qual. Result 21(1), 118 (2023)

Obradovic, M., LAL, A., LIEDGENS, H.: Effectiveness and Response of Chronic Pain Euroqol-5 Dimension (EQ-5D) Health Qual. Result 11110 (2013)

Poór, Ak, Rencz, F., Brodszky, V. etc, etc. Qual. Life res. 26(12), 3409–3419 (2017)

Kennedy-Martin, M., Slaap, B., Herdman, M., Van Reenen, M., Kennedy-Martin, T., Greiner, W., Busschbach, J., Boye, KS: A multiple orthodox utility tool is used for cost-useful analysis for any multiple orthodox utility tools Is it recommended? National Health Technology Assessment (HTA) Review. EUR. J. Health Econ. 21(8), 1245–1257 (2020)